3rd REsolution & 7th RESOLUTE Consortia Meetings

31.10.2022

The consortia meetings of REsolution and RESOLUTE took place in Berlin. The event, hosted by Bayer, gathered 60 international participants. On October 19, 2022, REsolution scientists worked in four groups to define the strategies for single-variant studies and SLC-family wide analyses. On October 20 and 21, 2022, the focus was on RESOLUTE scientific progress.

In the last years, RESOLUTE has developed many biological resources and data sets focused on SLCs. In the last year of the project, it is the perfect time to use the project’s data sets in high-impact scientific articles. To that end, scientists presented the most promising sub-projects, and they got key feedback to perform the final experiments.

Another highlight of the event was the three keynote lectures presented by Melissa Miller (Pfizer), Michael Brands (Bayer) and Avner Schlessinger (Icahn School of Medicine at Mount Sinai). The final session was the RESOLUTE training activity: speed dating for participants to discuss a variety of topics one-to-one.

Thank you to all participants for joining the event and engaging in meaningful exchanges with all partners, and to special thanks to the speakers for their excellent presentations!

And from our side, as always, we want to thank the organizers of these events!

 More News

Project
 

InSilify DrugTox is amongst the seven projects that were granted by the Austrian Science Fund FWF to enable research on different possibilities to...

News
 

We warmly welcome Sharath to the Pharminfo group! His expertise includes AI-assisted drug discovery and cheminformatics. We look forward to working...

Project
 

We are excited that our project AI4Health - Using AI for detecting drug-drug interactions - was recently granted by the Vienna Business Agency.